Probio-M9 reduces food allergy markers Probio-M9 alleviates OVA-sensitized food allergy through modulating gut microbiota and its metabolism.
We investigated how Probio-M9, a probiotic found in human milk, affects food allergies in mice sensitized to ovalbumin (OVA). Our study showed that administering live Probio-M9 significantly lowered levels of allergy markers like specific IgE and histamine, which are key in allergic reactions.
Importantly, Probio-M9 also shifted immune responses towards a more balanced state, reducing allergy-related inflammation. The analysis revealed beneficial changes in gut bacteria and an increase in short-chain fatty acids, which play a role in maintaining health.
Overall, our results suggest that Probio-M9 could be a promising approach to prevent food allergies.
Read More
Probiotics reduce allergy symptoms[The results of the use of a combined probiotic ( and spp. ВB-12) in children with gastrointestinal and skin manifestations of food allergy].
We investigated the effectiveness of a combined probiotic treatment for young children suffering from food allergies that affected their skin and digestive systems. In a randomized controlled study involving 92 children, those taking the probiotics saw a notable decrease in allergy symptoms and a significant drop in immunoglobulin E levels—an antibody linked with allergic reactions.
After 21 days of treatment, skin issues improved, while gastrointestinal symptoms like bloating and discomfort were also reduced. Although some symptoms returned over the next five months, the overall health of the group remained significantly better compared to those who didn’t receive the treatment.
Read More
Lactobacillus rhamnosus DNA affects allergiesProbiotic DNA regulates intestinal Th2 polarization by inducing epithelial cells to produce PD-L1.
We explored how Lactobacillus rhamnosus DNA might affect allergic responses linked to Th2 polarization. Using a specific protocol in mice, we administered LR-DNA daily for five days and observed its impact on intestinal cells. The results showed that LR-DNA increased PD-L1 expression in these cells, which then helped trigger the death of Th2 cells.
Importantly, while we found promising effects, the study suggests that just the DNA from the probiotic—not the live bacteria—was effective in reducing allergic responses.
Read More
Probiotics enhance food allergy treatmentProbiotics and other adjuvants in allergen-specific immunotherapy for food allergy: a comprehensive review.
We examined how probiotics, especially Lactobacillus rhamnosus, can improve treatments for food allergies through allergen-specific immunotherapy (FA-AIT). These helpful bacteria promote better immune responses, leading to increased tolerance. Clinical trials revealed that combining Lactobacillus rhamnosus with peanut immunotherapy led to better desensitization rates and positive immune changes.
While FA-AIT remains under study, integrating probiotics into these treatments appears promising for achieving lasting relief from allergies and improving patient well-being.
Read More
Lr improves lung inflammation managementLactobacillus rhamnosus Modulates Lung Inflammation and Mitigates Gut Dysbiosis in a Murine Model of Asthma-COPD Overlap Syndrome.
We sought to understand how Lactobacillus rhamnosus (Lr) influences lung inflammation and gut health in asthma-COPD overlap syndrome (ACOS). In an experimental study with mice, we introduced Lr treatment after inducing ACOS.
Our findings indicated that Lr treatment reduced lung inflammation, bronchial hyperreactivity, and improved gut microbiota diversity. Specifically, Lr lowered the levels of pro-inflammatory cytokines and restored beneficial immune markers. This study reveals that Lr could play a role in managing symptoms of ACOS by modulating both lung inflammation and gut dysbiosis.
Read More